See more : Fuso Pharmaceutical Industries,Ltd. (4538.T) Income Statement Analysis – Financial Results
Complete financial analysis of Sugi Holdings Co.,Ltd. (7649.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sugi Holdings Co.,Ltd., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Central Wireless, Inc. (CWIR) Income Statement Analysis – Financial Results
- Greenyn Biotechnology Co., Ltd (6846.TWO) Income Statement Analysis – Financial Results
- Electromed, Inc. (ELMD) Income Statement Analysis – Financial Results
- Alderan Resources Limited (AL8.AX) Income Statement Analysis – Financial Results
- IwaiCosmo Holdings, Inc. (8707.T) Income Statement Analysis – Financial Results
Sugi Holdings Co.,Ltd. (7649.T)
About Sugi Holdings Co.,Ltd.
Sugi Holdings Co.,Ltd. operates drugstores in Japan. It also provides visiting nursing services and home care support services. As of June 1, 2019, the company operated 1,190 stores. Sugi Holdings Co.,Ltd. was founded in 1976 and is headquartered in Obu, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 744.48B | 667.65B | 625.48B | 602.51B | 541.96B | 488.46B | 457.05B | 430.80B | 414.89B | 383.64B | 365.20B | 343.61B | 327.27B | 304.73B | 293.51B | 272.20B | 248.13B | 217.23B | 139.11B | 118.10B |
Cost of Revenue | 515.64B | 465.12B | 433.99B | 421.22B | 379.78B | 346.16B | 325.48B | 310.79B | 299.17B | 278.02B | 264.37B | 249.86B | 239.50B | 224.11B | 217.22B | 200.96B | 185.15B | 162.48B | 104.09B | 88.47B |
Gross Profit | 228.84B | 202.52B | 191.49B | 181.29B | 162.18B | 142.30B | 131.57B | 120.01B | 115.71B | 105.63B | 100.83B | 93.75B | 87.77B | 80.62B | 76.29B | 71.24B | 62.99B | 54.75B | 35.02B | 29.63B |
Gross Profit Ratio | 30.74% | 30.33% | 30.62% | 30.09% | 29.92% | 29.13% | 28.79% | 27.86% | 27.89% | 27.53% | 27.61% | 27.28% | 26.82% | 26.46% | 25.99% | 26.17% | 25.38% | 25.20% | 25.18% | 25.09% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.02B | 441.00M | 287.00M | 284.00M | 53.00M | 248.00M | 3.29B | 2.87B |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.72B | 3.37B |
SG&A | 192.22B | 170.87B | 159.35B | 147.59B | 132.42B | 116.48B | 106.80B | 97.18B | 92.60B | 84.76B | 80.72B | 75.33B | 1.02B | 441.00M | 287.00M | 284.00M | 53.00M | 248.00M | 7.01B | 6.25B |
Other Expenses | 1.00M | 818.00M | 1.16B | 1.64B | 1.88B | 1.46B | 1.17B | 1.03B | 718.00M | 906.00M | 855.00M | 1.60B | 1.94B | 2.22B | 1.98B | 1.51B | 1.06B | 750.00M | 587.40M | 718.58M |
Operating Expenses | 192.22B | 170.86B | 159.35B | 147.59B | 132.42B | 116.48B | 106.80B | 97.17B | 92.59B | 84.76B | 80.72B | 75.33B | 43.28B | 41.57B | 41.27B | 37.37B | 33.15B | 28.73B | 27.84B | 23.37B |
Cost & Expenses | 707.86B | 635.99B | 593.34B | 568.81B | 512.20B | 462.65B | 432.28B | 407.96B | 391.77B | 362.78B | 345.10B | 325.19B | 282.77B | 265.68B | 258.49B | 238.33B | 218.29B | 191.21B | 131.93B | 111.84B |
Interest Income | 602.00M | 160.00M | 84.00M | 88.00M | 93.00M | 101.00M | 108.00M | 126.00M | 185.00M | 175.00M | 176.00M | 173.00M | 169.00M | 179.00M | 168.00M | 255.00M | 213.00M | 110.00M | 42.22M | 19.93M |
Interest Expense | 15.00M | 16.00M | 19.00M | 21.00M | 22.00M | 25.00M | 26.00M | 27.00M | 24.00M | 20.00M | 19.00M | 13.00M | 13.00M | 14.00M | 14.00M | 12.00M | 84.00M | 22.00M | 21.58M | 0.00 |
Depreciation & Amortization | 14.12B | 12.36B | 11.27B | 9.94B | 8.41B | 7.39B | 6.46B | 5.60B | 5.27B | 4.95B | 4.99B | 4.79B | 3.77B | 3.74B | 3.64B | 2.58B | 2.55B | 2.31B | 1.28B | 1.06B |
EBITDA | 46.24B | 44.02B | 43.41B | 43.64B | 38.17B | 33.21B | 31.22B | 28.43B | 28.38B | 25.81B | 25.10B | 26.88B | 23.34B | 17.89B | 11.99B | 13.51B | 15.03B | 10.96B | 7.72B | 6.69B |
EBITDA Ratio | 6.21% | 6.74% | 7.14% | 7.54% | 7.41% | 7.14% | 7.11% | 6.87% | 7.07% | 7.01% | 7.16% | 7.27% | 15.39% | 14.83% | 13.90% | 14.04% | 13.56% | 13.44% | 6.54% | 7.35% |
Operating Income | 36.62B | 31.66B | 32.14B | 33.70B | 29.76B | 25.82B | 24.76B | 22.83B | 23.11B | 20.86B | 20.10B | 18.42B | 17.22B | 12.78B | 10.15B | 11.85B | 10.88B | 9.25B | 5.94B | 5.06B |
Operating Income Ratio | 4.92% | 4.74% | 5.14% | 5.59% | 5.49% | 5.29% | 5.42% | 5.30% | 5.57% | 5.44% | 5.50% | 5.36% | 5.26% | 4.19% | 3.46% | 4.35% | 4.38% | 4.26% | 4.27% | 4.28% |
Total Other Income/Expenses | -4.52B | -3.47B | -4.68B | -2.52B | 164.00M | 236.00M | -201.00M | -311.00M | -286.00M | 27.00M | 1.08B | 3.66B | 2.18B | 1.08B | -2.08B | -929.00M | 1.51B | -616.00M | 471.13M | 579.55M |
Income Before Tax | 32.10B | 28.18B | 27.46B | 31.52B | 29.93B | 26.05B | 24.56B | 22.52B | 22.83B | 20.89B | 21.19B | 22.08B | 19.40B | 13.85B | 8.06B | 10.92B | 12.39B | 8.63B | 6.41B | 5.64B |
Income Before Tax Ratio | 4.31% | 4.22% | 4.39% | 5.23% | 5.52% | 5.33% | 5.37% | 5.23% | 5.50% | 5.44% | 5.80% | 6.42% | 5.93% | 4.55% | 2.75% | 4.01% | 4.99% | 3.97% | 4.61% | 4.77% |
Income Tax Expense | 10.12B | 9.18B | 8.07B | 10.40B | 9.14B | 8.11B | 8.15B | 7.57B | 8.22B | 8.03B | 8.37B | 9.45B | 7.97B | 4.85B | 2.88B | 5.54B | 5.54B | 3.86B | 2.67B | 2.50B |
Net Income | 21.98B | 19.01B | 19.39B | 21.12B | 20.78B | 17.94B | 16.41B | 14.95B | 14.61B | 12.86B | 12.82B | 12.63B | 11.43B | 9.00B | 5.18B | 5.37B | 6.86B | 4.00B | 3.74B | 3.14B |
Net Income Ratio | 2.95% | 2.85% | 3.10% | 3.51% | 3.83% | 3.67% | 3.59% | 3.47% | 3.52% | 3.35% | 3.51% | 3.68% | 3.49% | 2.95% | 1.76% | 1.97% | 2.76% | 1.84% | 2.69% | 2.66% |
EPS | 121.46 | 103.82 | 104.56 | 113.89 | 112.07 | 99.14 | 259.20 | 236.08 | 230.67 | 203.15 | 202.48 | 199.47 | 180.46 | 142.14 | 81.82 | 84.88 | 108.27 | 66.91 | 141.68 | 120.08 |
EPS Diluted | 121.46 | 103.82 | 104.56 | 113.89 | 112.07 | 99.14 | 259.20 | 236.08 | 230.67 | 203.15 | 202.48 | 199.47 | 180.46 | 142.14 | 81.82 | 84.88 | 108.27 | 66.91 | 141.68 | 120.08 |
Weighted Avg Shares Out | 180.96M | 183.09M | 185.44M | 185.44M | 185.44M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M |
Weighted Avg Shares Out (Dil) | 180.96M | 183.09M | 185.44M | 185.44M | 185.44M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M | 180.96M |
Source: https://incomestatements.info
Category: Stock Reports